Share price
$1.23
As of Apr 29, 2026
QNCX | NASDAQ | Biotechnology
Quince Therapeutics, Inc.
Quince Therapeutics, Inc. (QNCX) | runway 1.2 months | financing risk high | market cap $20M. Daily snapshot of financials, capital pressure, and recent deve...
Company websiteLast updated Apr 29, 2026
Market cap
$20M
Snapshot valuation
30D volume
8.8M shares
Rolling average daily volume
Runway
1.2 months
Estimated from precomputed burn and cash
Financing risk
N/A
The company screens as likely to return to the capital markets soon.
Snapshot summary
Runway: 1.2 months based on estimated burn.
Recent financing detected on Oct 16, 2025.
Financing signal: The company screens as likely to return to the capital markets soon.
Recent developments
Quince Therapeutics, Inc. 8-K 2026-04-28
8-K filed on 2026-04-28.
Quince Therapeutics, Inc. 8-K 2026-04-22
8-K filed on 2026-04-22.
Quince Therapeutics, Inc. PRE 14A 2026-04-17
PRE 14A filed on 2026-04-17.
Quince Therapeutics, Inc. S-8 2026-04-17
S-8 filed on 2026-04-17.
Quince Therapeutics, Inc. 10-K 2026-04-10
Quince Therapeutics filed its annual report, which includes corporate governance updates and discussion of listing and strategic matters.
Related screens
Low cash runway companies
Companies screening with the shortest estimated runway based on precomputed burn and cash snapshots.
High burn rate companies
Companies with the highest estimated trailing cash burn across the monitored issuer set.
Recent financing disclosures
Companies with recent financing activity, capital raises, or post-balance-sheet funding events.
Pre-market filings
Companies with recent filings or disclosures posted before the market open.
Related companies
Recent documents
Quince Therapeutics, Inc. 8-K 2026-04-28
8-K filed on 2026-04-28.
Apr 27, 2026Open source
Quince Therapeutics, Inc. 8-K 2026-04-22
8-K filed on 2026-04-22.
Apr 21, 2026Open source
Quince Therapeutics, Inc. S-8 2026-04-17
S-8 filed on 2026-04-17.
Apr 16, 2026Open source
Quince Therapeutics, Inc. PRE 14A 2026-04-17
PRE 14A filed on 2026-04-17.
Apr 16, 2026Open source
Premium analysis
Full filing analysis and proprietary signal detail
Detailed impact scoring, historical financial trends, full filing analysis, premium alerts, and proprietary signal explanations stay behind login and subscription.
Full filing analysis with event-level impact scoring
Historical financial trends and runway context
Detailed signal breakdowns and proprietary explanations
Premium alerts, filters, and watchlist workflows
Deeper financing and dilution analysis
Timeline context across filings and disclosures